BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 13, 2002
View Archived Issues
Myriad, Abbott Team In Deal To Diagnose, Treat Depression
Myriad Genetics Inc. entered a deal worth upward of $34 million with Abbott Laboratories Inc. to identify genes and drug targets for the diagnosis and treatment of depression. (BioWorld Today)
Read More
Ricerca Licenses Cancer Gene; CRO Embraces New Paradigm’
Read More
Classic Mutant Mouse With Multi- Neuronal Disorders Shines Light On Potential Human Manipulation
Read More
Alexion, CuraGen Seek Cancer Targets For Drug Development
Read More
Phenomix’s Forward Genetics’ Gets $32M Funding Commitment
Read More
Other News To Note
Read More
Senomyx Raises $36.8M Privately To Fund Taste, Smell Programs
Read More